Dr Matthew Rieke

KANDO id: 6138

Bio

Founding Principal of Quaker BioVentures and promoted to Partner in 2005. Previously: Principal at PA Early Stage, a venture capital fund investing in early stage life science and IT companies. Created startup companies based on Penn faculty inventions at the University of Pennsylvania Center for Technology Transfer. Management consultant with CSC Healthcare, focusing on disease management protocols. Researched novel therapeutics and bone marrow transplantation at Cedars-Sinai Medical Center. Neotropix, Nitric BioTherapeutics, Tarsa Therapeutics, TearScience and TransEnterix. BA from Colgate University, Doctor of Medicine from the University of Pennsylvania School of Medicine, MBA from the Wharton School of the University of Pennsylvania. Maintains active medical license.

Education